Skip to main content
. 2022 Jun 3:1–22. Online ahead of print. doi: 10.1007/s11469-022-00846-6

Table 2.

Main methodological and intervention characteristics of each study

No Authors Year Country Age Method Arms (n) Measures Intervention No and length of sessions Profile
1 Du et al 2010 China 12–17 Es

CG = 24

EG = 32

BDQIA, IOS-S, TMDS, SDQ, SCARED EG = CBT CBT = 8 (90–120 min) G
2 Gholamian et al 2019 Iran 16–17 QeS

CG = 60

EG = 60

BASNEF, NSKQ, YDQ EG = BASNEF BASNEF = 2 (NA) G
3 Hui et al 2017 China 19–25 RCT

CG = 37

EG1 = 39

EG2 = 36

YDQ, SCL-90, P50

EG1 = EA

EG2 = CT

EG3 = EA + CT

EA = 10 (30 min)

CBT = 5 (30 min)

G + I
4 Ke et al. (a) 2018 Malaysia 13–18 QeS EG = 4 5 PIUQ, DASS-42, SIAS EG = CBT CBT = 8 (90 min) G
5 Ke et al. (b) 2018 Malaysia 13–18 QeS EG = 157 PIUQ, DASS -42, SIAS EG = CBT CBT = 8 (90 min) G
6 Khazaei et al 2017 Iran 20–30 RCT

CG = 24

EG = 24

YDQ, Y-BOCS, QRI, SI EG = PP PP = 10 (NA) G
7 Kim et al 2018 South Korea 12–17 QeS EG = 17 K-scale, YDQ, IAS, CDI, STAI EG = CBT CBT = 8 (120 min) G
8 Pan 2020 China 13–18 QeS

CG = 10

EG1 = 10

EG2 = 10

EG3 = 10

YDQ

EG1 = CBT

EG2 = PE

EG3 = CBT + PE

NA G + I
9 Quinones et al 2019 UK 39–42 RCT

CG = 148

EG1 = 343

EG2 = 151

CIU, FFMQ, PHQ-ADS

EG1 = MDF

EG2 = GR

Using app = 14 (10 min) I
10 Santos et al 2017 Brazil 18–65 QeS

EG1 = 42

EG2 = 42

IAT, HAM-A, HDRS, CGI

EG1 = PPE

EG2 = CBT + pharmacotherapy

CBT = 8–10 (NA) G + I
11 Tas et al 2018 Turkey 15 QeS

CG = 12

EG = 12

YDQ, SCL-90 EG = PPE PPE = 10 (50 min) G
12 Thorens et al 2014 Swiss 13–67 QeS EG = 57 ACP, IAT EG = CBT CBT = 6 (50 min) Individual
13 Yang et al 2017 China 18–30 RCT

EG1 = 15

EG2 = 14

IAS, BIS-11, MRS

EG1 = EA

EG2 = PP

EA = 45 (30 min)

PP = 11 (120 min)

G + I
14 Young 2013 EUA 22–56 QeS EG = 128 COQ, IAT EG = CBT CBT = 12 (NA) -
15 Zhu et al 2012 China 19–25 RCT

EG1 = 39

EG2 = 36

EG3 = 37

IAT, WMS

EG1 = EA

EG2 = CT

EG3 = EA + CT

EA = 10 (30 min)

CBT = 5 (30 min)

G + I

Legend: Es, experimental study; QeS, quasi-experimental study; CG, control group; EG, experimental groups; CBT, cognitive-behavioral therapy; PP, positive psychology; G, group therapy; I, individual therapy; EA, electroacupuncture; CT, comprehensive therapy; PPE, psychoeducational program; PE, physical exercise; APP, applicative; MDF, mindfulness; GR, gradual relaxation; BASNEF, Belief, Attitude, Subjective Norm, and Enabling Factors; NA, not available; BDQIA, Beard’s Diagnostic Questionnaire for Internet addiction; IOS-S, Internet Overuse Self-Rating Scale; TMDS, Time Management Disposition Scale; SDQ, Strength and Difficulties Questionnaire; SCARED, Screen for Child Anxiety Related Emotional Disorders; BASNEF, Belief, Attitude, Subjective Norm, and Enabling Factors; NSKQ, Knowledge Questionnaire; YDQ, Young’s Diagnostic Questionnaire; SCL-90, Brief Symptom Inventory; PIUQ, Problematic Internet Use Questionnaire; DASS, Depression, Anxiety, Stress Scales; SIAS, Social Interaction Anxiety Scale; Y-BOCS, Yale–Brown Obsessive Compulsive Scale; QRI, Quality of Relationships nventory); SI, severity of Internet use; K-scale, Korean Internet addiction self-report test; IAS, Young’s Internet Addiction Scale; CDI, Children’s Depression Inventory; STAI, State-Trait Anxiety Inventory; CIU, Compulsive Internet use; FFMQ, Five Facet Mindfulness Questionnaire; PHQ-ADS, Patient Health Questionnaire Anxiety and Depression Scale; IAT Internet addiction test; HAM-A, Hamilton Anxiety Scale; HDRS, Hamilton Depression Scale; CGI, Clinical Global Impressions; SCL-90, Brief Symptom Inventory; ACP, Avaliação clínica psiquiatrica; BIS-11, Barratt Impulsiveness Scale; MRS, Magnetic Resonance System; COQ, client outcome questionnaire); WMS, Wechsler Memory Scale